Medication shows promise for weight loss in patients with obesity, diabetes
One in 10 UK adults say brain health has deteriorated in pandemic
13 January 2021Study: In pandemic era, older adults isolated but resilient
13 January 2021Medication shows promise for weight loss in patients with obesity, diabetes
A new study confirms that treatment with Bimagrumab, an antibody that blocks activin type II receptors and stimulates skeletal muscle growth, is safe and effective for treating excess adiposity and metabolic disturbances of adult patients with obesity and type 2 diabetes.
